668455-64-9 Usage
Heterocyclic aromatic organic compound
1H-Indole, 3-(4-chlorophenoxy)-2-methyl-6-(trifluoromethoxy)is a derivative of indole, which is a heterocyclic aromatic organic compound.
Molecular weight
The molecular weight of 1H-Indole, 3-(4-chlorophenoxy)-2-methyl-6-(trifluoromethoxy)- is 375.735 g/mol.
Use in pharmaceutical research and development
This chemical is commonly used in pharmaceutical research and development, as well as in the synthesis of various organic compounds.
Potential as a building block in the synthesis of biologically active compounds
1H-Indole, 3-(4-chlorophenoxy)-2-methyl-6-(trifluoromethoxy)is known for its potential as a building block in the synthesis of biologically active compounds.
Role as a research tool in medicinal chemistry
1H-Indole, 3-(4-chlorophenoxy)-2-methyl-6-(trifluoromethoxy)- serves as a research tool in medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 668455-64-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,6,8,4,5 and 5 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 668455-64:
(8*6)+(7*6)+(6*8)+(5*4)+(4*5)+(3*5)+(2*6)+(1*4)=209
209 % 10 = 9
So 668455-64-9 is a valid CAS Registry Number.
668455-64-9Relevant academic research and scientific papers
INDOLES HAVING ANTI-DIABETIC ACTIVITY
-
Page/Page column 30, (2008/06/13)
Indoles of Formula (I) having -X-aryl-(CH2)x#191-oxazolidinedione and -X-heteroaryl-(CH2)X-oxazolidinedione substituents on the N atom of the indole ring, where x is 0 or 1, and -X-is a bond or -CH2-, and their thiazolidinedione analogs, are PPAR gamma agonists or partial agonists and are useful in the treatment and control of type II diabetes, including hyperglycemia, dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes.
INDOLES HAVING ANTI-DIABETIC ACTIVITY
-
Page 64, (2010/02/06)
Indoles having aryloxyalkanoic acid substituents or arylalkanoic acid substituents are agonists or partial agonists of PPAR gamma and are useful in the treatment and control of hyperglycemia that is symptomatic of type II diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes.
